Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 65

Results For "CENT"

4841 News Found

Pawan Varshney elevated to Director of Finance – South Asia at Cepheid
People | May 01, 2026

Pawan Varshney elevated to Director of Finance – South Asia at Cepheid

His appointment is expected to further strengthen the company’s financial governance and regional operational strategy across South Asia


PFCD panel flags insurance gaps limiting access to robotic joint replacement in India
Healthcare | May 01, 2026

PFCD panel flags insurance gaps limiting access to robotic joint replacement in India

Leading orthopaedic experts call for equitable insurance coverage to patients for accessing advanced, precision-driven joint replacement technologies


Syngene appoints Maninder Kapoor Puri as CHRO and Abhijit Zutshi as CCO
People | May 01, 2026

Syngene appoints Maninder Kapoor Puri as CHRO and Abhijit Zutshi as CCO

Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion


Fortis Cancer Summit 2026 to unite global oncology leaders in New Delhi
Hospitals | May 01, 2026

Fortis Cancer Summit 2026 to unite global oncology leaders in New Delhi

The summit will bring together 1,200+ delegates, 100+ international faculty from 25 countries


Dr Reddy’s becomes first to secure Health Canada nod for generic Semaglutide injection
Drug Approval | May 01, 2026

Dr Reddy’s becomes first to secure Health Canada nod for generic Semaglutide injection

Market authorization for generic GLP-1 therapy strengthens company’s diabetes portfolio in Canada


Laurus Labs FY26 revenue rises 23% to Rs 6,813 Crore; EBITDA surges 64%
Biopharma | May 01, 2026

Laurus Labs FY26 revenue rises 23% to Rs 6,813 Crore; EBITDA surges 64%

Strong CDMO growth, improved product mix and operational leverage drive profitability expansion


Fabtech Technologies FY26 revenue rises 28% to Rs 431 crore
News | May 01, 2026

Fabtech Technologies FY26 revenue rises 28% to Rs 431 crore

Pharma and biotech infrastructure firm targets 25–30% growth as Middle East and Africa emerge as key expansion markets


JP Nadda highlights India’s push for APIs, biologics and translational research
Policy | May 01, 2026

JP Nadda highlights India’s push for APIs, biologics and translational research

On his visit to NIPER Mohali, union health minister vreviews biopharma research initiatives and calls for stronger industry collaboration and commercialization focus


Merck KGaA launches Phase 3 push for lupus skin disease with enpatoran trials
News | May 01, 2026

Merck KGaA launches Phase 3 push for lupus skin disease with enpatoran trials

The trials -- ELOWEN-1 and ELOWEN-2 -- are designed to evaluate the drug in people living with lupus who experience active skin manifestations


Our hybrid model combines global manufacturing with local clinical scale: Kavinder Beniwal, Chief Operational Officer, Motorica India
interviews | April 30, 2026

Our hybrid model combines global manufacturing with local clinical scale: Kavinder Beniwal, Chief Operational Officer, Motorica India

With the convergence of AI, robotics, and neuroscience, Motorica is advancing toward more intuitive, intent-driven prosthetic systems